🇯🇵 EBGLYSS in Japan

EBGLYSS (LEBRIKIZUMAB-LBKZ) regulatory status in Japan.

Marketing authorisation

EBGLYSS in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Japan

Frequently asked questions

Is EBGLYSS approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for EBGLYSS in Japan?

ELI LILLY AND CO is the originator. The local marketing authorisation holder may differ — check the official source linked above.